Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1016/j.bbmt.2015.10.005

Type

Journal article

Journal

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Publication Date

03/2016

Volume

22

Pages

432 - 440

Keywords

JAK1/2 inhibitors, Ruxolitinib, Myelofibrosis, Allogeneic transplantation, Survival